2023 Q1 Form 10-Q Financial Statement

#000121390023010734 Filed on February 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $87.00K $2.000K $0.00
YoY Change -62.82%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.020M $2.896M $4.288M
YoY Change -33.67% -32.46% -15.92%
% of Gross Profit
Research & Development $4.333M $4.575M $6.541M
YoY Change -30.93% -30.06% -18.24%
% of Gross Profit
Depreciation & Amortization $88.00K $97.00K $327.0K
YoY Change -64.94% -70.34% -6.57%
% of Gross Profit
Operating Expenses $4.333M $4.575M $10.80M
YoY Change -59.54% -57.62% -17.41%
Operating Profit -$7.100M -$6.679M -$10.80M
YoY Change -32.22% -38.13% -17.41%
Interest Expense -$217.0K -$212.0K -$145.0K
YoY Change -138.96% 46.21% -127.88%
% of Operating Profit
Other Income/Expense, Net -$441.0K -$1.363M
YoY Change
Pretax Income -$7.758M -$8.254M -$10.94M
YoY Change -21.78% -24.55% -12.83%
Income Tax
% Of Pretax Income
Net Earnings -$7.624M -$8.117M -$10.94M
YoY Change -23.13% -25.8% -12.83%
Net Earnings / Revenue -8763.22% -405850.0%
Basic Earnings Per Share -$0.19 -$0.24 -$0.34
Diluted Earnings Per Share -$0.19 -$0.24 -$340.4K
COMMON SHARES
Basic Shares Outstanding 39.81M shares 32.66M shares 32.14M shares
Diluted Shares Outstanding 39.95M shares 33.19M shares 32.14M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.17M $47.25M $58.18M
YoY Change -28.74% -18.8% 35.15%
Cash & Equivalents $3.677M $8.818M $18.72M
Short-Term Investments $40.49M $38.43M $39.47M
Other Short-Term Assets $2.519M $2.894M $1.970M
YoY Change 7.97% 46.9% -10.45%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $46.69M $50.14M $60.15M
YoY Change -27.41% -16.65% 32.93%
LONG-TERM ASSETS
Property, Plant & Equipment $681.0K $673.0K $9.331M
YoY Change -92.55% -92.79% 197.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.97M
YoY Change 248.1%
Other Assets $2.000K $97.00K $735.0K
YoY Change -99.86% -86.8% 2.08%
Total Long-Term Assets $9.554M $9.787M $21.03M
YoY Change -35.51% -53.46% 200.01%
TOTAL ASSETS
Total Short-Term Assets $46.69M $50.14M $60.15M
Total Long-Term Assets $9.554M $9.787M $21.03M
Total Assets $56.24M $59.93M $81.18M
YoY Change -28.92% -26.18% 55.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.453M $1.257M $4.058M
YoY Change -63.14% -69.02% 42.39%
Accrued Expenses $1.335M $1.507M $5.537M
YoY Change -65.59% -72.78% 13.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.377M $5.284M $9.595M
YoY Change -31.26% -44.93% -4.05%
LONG-TERM LIABILITIES
Long-Term Debt $23.35M $22.68M $23.16M
YoY Change 1.84% -2.09%
Other Long-Term Liabilities $6.637M $7.002M $8.591M
YoY Change -19.43% -18.5% 667.05%
Total Long-Term Liabilities $29.98M $29.68M $31.75M
YoY Change -3.78% -6.53% 2734.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.377M $5.284M $9.595M
Total Long-Term Liabilities $29.98M $29.68M $31.75M
Total Liabilities $35.36M $34.96M $41.34M
YoY Change -13.83% -15.44% 271.8%
SHAREHOLDERS EQUITY
Retained Earnings -$393.1M -$385.5M
YoY Change
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.06M $23.19M $39.84M
YoY Change
Total Liabilities & Shareholders Equity $56.24M $59.93M $81.18M
YoY Change -28.92% -26.18% 55.35%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$7.624M -$8.117M -$10.94M
YoY Change -23.13% -25.8% -12.83%
Depreciation, Depletion And Amortization $88.00K $97.00K $327.0K
YoY Change -64.94% -70.34% -6.57%
Cash From Operating Activities -$6.071M -$6.280M -$9.863M
YoY Change -35.57% -36.33% 25.8%
INVESTING ACTIVITIES
Capital Expenditures $24.00K $68.00K -$29.00K
YoY Change -164.86% -334.48% -122.31%
Acquisitions
YoY Change
Other Investing Activities -$1.664M $737.0K $14.34M
YoY Change -121.61% -94.86% 86.29%
Cash From Investing Activities -$1.688M $669.0K $14.32M
YoY Change -122.03% -95.33% 89.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.341M 5.693M 0.000
YoY Change -68.79% -100.0%
NET CHANGE
Cash From Operating Activities -6.071M -6.280M -9.863M
Cash From Investing Activities -1.688M 669.0K 14.32M
Cash From Financing Activities 2.341M 5.693M 0.000
Net Change In Cash -5.418M 82.00K 4.452M
YoY Change -194.37% -98.16% 527.04%
FREE CASH FLOW
Cash From Operating Activities -$6.071M -$6.280M -$9.863M
Capital Expenditures $24.00K $68.00K -$29.00K
Free Cash Flow -$6.095M -$6.348M -$9.834M
YoY Change -35.06% -35.45% 23.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33194622 shares
plur Noncontrolling Interest In Plurinuva Ltd
NoncontrollingInterestInPlurinuvaLtd
usd
plur Expiration Of Warrants
ExpirationOfWarrants
usd
CY2022Q4 plur Net Of Issuance Costs
NetOfIssuanceCosts
361000 usd
CY2022Q4 plur Expiration Of Warrants
ExpirationOfWarrants
usd
CY2022Q4 plur Net Of Issuance Costs
NetOfIssuanceCosts
361000 usd
CY2022Q4 plur Expiration Of Warrants
ExpirationOfWarrants
usd
plur Proceeds From Withdrawal Of Longterm Deposits
ProceedsFromWithdrawalOfLongtermDeposits
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29677000 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29050000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38291151 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38291151 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32507491 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32507491 shares
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
408692000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
401302000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-385501000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-371263000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23191000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
30039000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1775000 usd
CY2022Q2 us-gaap Minority Interest
MinorityInterest
2147000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24966000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59927000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32186000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
68065000 usd
us-gaap Revenues
Revenues
89000 usd
CY2022Q4 us-gaap Revenues
Revenues
2000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9079000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12932000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4575000 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6541000 usd
plur Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
1023000 usd
plur Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
72000 usd
CY2022Q4 plur Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
790000 usd
CY2021Q4 plur Government And Third Party Grants Received
GovernmentAndThirdPartyGrantsReceived
34000 usd
plur Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
8056000 usd
plur Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
12860000 usd
CY2022Q4 plur Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
3785000 usd
CY2021Q4 plur Research And Development Expenses Net
ResearchAndDevelopmentExpensesNet
6507000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5635000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9376000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2896000 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4288000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-13602000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22236000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6679000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-10795000 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31392
dei Entity Registrant Name
EntityRegistrantName
PLURI INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0351734
dei Entity Address Address Line1
EntityAddressAddressLine1
MATAM Advanced Technology Park
dei Entity Address Address Line2
EntityAddressAddressLine2
Building No. 5
dei Entity Address City Or Town
EntityAddressCityOrTown
Haifa
dei Entity Address Country
EntityAddressCountry
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
3508409
dei Security12b Title
Security12bTitle
Common Shares, par value $0.00001
dei Trading Symbol
TradingSymbol
PLUR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39807172 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8818000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9772000 usd
CY2022Q4 plur Shortterm Bank Deposits
ShorttermBankDeposits
38428000 usd
CY2022Q2 plur Shortterm Bank Deposits
ShorttermBankDeposits
45244000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
753000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
1007000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2141000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1724000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
50140000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
57747000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
597000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
634000 usd
CY2022Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
543000 usd
CY2022Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
661000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
673000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
739000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7877000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8270000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
97000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14000 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
9787000 usd
CY2022Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
10318000 usd
CY2022Q4 us-gaap Assets
Assets
59927000 usd
CY2022Q2 us-gaap Assets
Assets
68065000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1257000 usd
CY2022Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1785000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1507000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1630000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
605000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
619000 usd
CY2022Q4 plur Accrued Vacations Current
AccruedVacationsCurrent
818000 usd
CY2022Q2 plur Accrued Vacations Current
AccruedVacationsCurrent
1053000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1097000 usd
CY2022Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1742000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5284000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6829000 usd
CY2022Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
763000 usd
CY2022Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
867000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6239000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6505000 usd
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
22675000 usd
CY2022Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
21678000 usd
plur Financial Expenses
FinancialExpenses
406000 usd
plur Financial Expenses
FinancialExpenses
453000 usd
CY2022Q4 plur Financial Expenses
FinancialExpenses
212000 usd
CY2021Q4 plur Financial Expenses
FinancialExpenses
225000 usd
plur Financial Income
FinancialIncome
-515000 usd
plur Financial Income
FinancialIncome
317000 usd
CY2022Q4 plur Financial Income
FinancialIncome
-1363000 usd
CY2021Q4 plur Financial Income
FinancialIncome
80000 usd
plur Financial Income Net
FinancialIncomeNet
-921000 usd
plur Financial Income Net
FinancialIncomeNet
-136000 usd
CY2022Q4 plur Financial Income Net
FinancialIncomeNet
-1575000 usd
CY2021Q4 plur Financial Income Net
FinancialIncomeNet
-145000 usd
us-gaap Profit Loss
ProfitLoss
-14523000 usd
us-gaap Profit Loss
ProfitLoss
-22372000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-8254000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-10940000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-285000 usd
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-137000 usd
us-gaap Net Income Loss
NetIncomeLoss
-14238000 usd
us-gaap Net Income Loss
NetIncomeLoss
-22372000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-8117000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10940000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.7
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32878434 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32068271 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33194622 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32136352 shares
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57151000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57151000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
57151000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5061000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5061000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5061000 usd
us-gaap Profit Loss
ProfitLoss
-22372000 usd
us-gaap Profit Loss
ProfitLoss
-22372000 usd
us-gaap Profit Loss
ProfitLoss
-22372000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39840000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39840000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39840000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48907000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1873000 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-10940000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39840000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32186000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1897000 usd
plur Net Of Issuance Costs
NetOfIssuanceCosts
361000 usd
plur Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
5406000 usd
us-gaap Profit Loss
ProfitLoss
-14523000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24966000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26901000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26901000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
26901000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
913000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
913000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
913000 usd
CY2022Q4 plur Net Of Issuance Costs
NetOfIssuanceCosts
361000 usd
CY2022Q4 plur Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
5406000 usd
CY2022Q4 plur Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
5406000 usd
CY2022Q4 plur Issuance Of Common Stock And Warrants
IssuanceOfCommonStockAndWarrants
5406000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-8254000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-8254000 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-8254000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24966000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24966000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
24966000 usd
us-gaap Profit Loss
ProfitLoss
-14523000 usd
us-gaap Profit Loss
ProfitLoss
-22372000 usd
us-gaap Depreciation
Depreciation
197000 usd
us-gaap Depreciation
Depreciation
664000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1897000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5061000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
500000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-50000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-517000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
69000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1290000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2036000 usd
plur Decrease In Operating Lease Right Of Use Asset And Liability
DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability
-113000 usd
plur Decrease In Operating Lease Right Of Use Asset And Liability
DecreaseInOperatingLeaseRight-Of-UseAssetAndLiability
168000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
388000 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
220000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
111000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1039000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
997000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-746000 usd
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
14000 usd
us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
7000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13889000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18652000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
141000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44000 usd
plur Proceeds From Withdrawal Of Shortterm Deposits
ProceedsFromWithdrawalOfShorttermDeposits
7203000 usd
plur Proceeds From Withdrawal Of Shortterm Deposits
ProceedsFromWithdrawalOfShorttermDeposits
-5539000 usd
plur Proceeds From Withdrawal Of Longterm Deposits
ProceedsFromWithdrawalOfLongtermDeposits
12658000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7062000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7075000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5693000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5693000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-111000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1039000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1245000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12616000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11413000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31838000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10168000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19222000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
8818000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value Including Discontinued Operations
CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations
18715000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
753000 usd
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
507000 usd
CY2022Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
597000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10168000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19222000 usd
CY2022Q4 plur Purchase Of Property And Equipment On Credit
PurchaseOfPropertyAndEquipmentOnCredit
15000 usd
CY2021Q4 plur Purchase Of Property And Equipment On Credit
PurchaseOfPropertyAndEquipmentOnCredit
23000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
287000 usd
CY2022Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
187500 shares
CY2022Q1 plur Additional Investment
AdditionalInvestment
7500000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0325 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.70 pure
plur Compensation Expense Recognized During The Period
CompensationExpenseRecognizedDuringThePeriod
385000 usd
us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-size: 10pt"><i>c.</i></span></td> <td><span style="font-size: 10pt"><b><i>Use of estimates</i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -1.35pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates, judgments and assumptions that are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify"> </p>
CY2022Q4 plur Cash And Deposits
CashAndDeposits
1350000 usd
plur Percentage Of Qualified Expenditures
PercentageOfQualifiedExpenditures
0.50 pure
plur Royalty Rate Sales
RoyaltyRateSales
0.03 pure
plur Royalty Rate Payable On Grants Received
RoyaltyRatePayableOnGrantsReceived
1 pure
CY2022Q4 plur Contingent Liability In Respect To Royalties
ContingentLiabilityInRespectToRoyalties
27574000 usd
CY2020Q2 plur Subsidiary Loan
SubsidiaryLoan
50000000 eur
CY2020Q2 plur Contract Period
ContractPeriod
36 months
plur Contractual Interest Rate For Funds Borrowed
ContractualInterestRateForFundsBorrowed
0.04 pure
plur Fixed Interest Rate
FixedInterestRate
0 pure
plur Deferred Interest Rate Percentage
DeferredInterestRatePercentage
0.04 pure
CY2021Q2 plur First Tranche Price
FirstTranchePrice
20000000 eur
CY2021Q2 plur Annual Interest Percentage
AnnualInterestPercentage
0.04 pure
CY2022Q4 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
21330000 usd
CY2022Q4 plur Accrued Interest
AccruedInterest
1345000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
11800000 usd
CY2022Q4 plur Aggregate Common Shares
AggregateCommonShares
8155900 shares
CY2022Q4 plur Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
8155900 shares
CY2022Q4 us-gaap Share Price
SharePrice
1.03
CY2022Q4 plur Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
5579883 shares
CY2022Q4 plur Purchase Of Common Shares
PurchaseOfCommonShares
5579833 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.03
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.06
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.09
CY2022Q4 plur Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
135000 shares
CY2022Q4 plur Purchase Of Common Shares
PurchaseOfCommonShares
135000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.09
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.12
CY2022Q4 plur Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
135000 shares
CY2022Q4 plur Purchase Of Common Shares
PurchaseOfCommonShares
135000 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.12
plur Issuance Of Shares Of Common Stock
IssuanceOfSharesOfCommonStock
5550121 shares
us-gaap Payments For Repurchase Of Private Placement
PaymentsForRepurchaseOfPrivatePlacement
5800000 usd
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
361000 usd
CY2023Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7015900 shares
plur Aggregate Gross Proceeds
AggregateGrossProceeds
7300000 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
6000 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
10000 usd
CY2022Q4 plur General And Administration Income
GeneralAndAdministrationIncome
6000 usd
CY2021Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
8000 usd
CY2022Q4 plur Annual Cash Salary
AnnualCashSalary
375000000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2079000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
139000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55000 usd
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
69000 usd
us-gaap Revenues
Revenues
usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
dei Entity Central Index Key
EntityCentralIndexKey
0001158780

Files In Submission

Name View Source Status
0001213900-23-010734-index-headers.html Edgar Link pending
0001213900-23-010734-index.html Edgar Link pending
0001213900-23-010734.txt Edgar Link pending
0001213900-23-010734-xbrl.zip Edgar Link pending
f10q1222ex10-2_pluriinc.htm Edgar Link pending
f10q1222ex31-1_pluriinc.htm Edgar Link pending
f10q1222ex31-2_pluriinc.htm Edgar Link pending
f10q1222ex32-1_pluriinc.htm Edgar Link pending
f10q1222ex32-2_pluriinc.htm Edgar Link pending
f10q1222_pluriinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
plur-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
plur-20221231_cal.xml Edgar Link unprocessable
plur-20221231_def.xml Edgar Link unprocessable
plur-20221231_pre.xml Edgar Link unprocessable
plur-20221231_lab.xml Edgar Link unprocessable
f10q1222_pluriinc_htm.xml Edgar Link completed